Artículos por temáticas

RAB32 -linked Parkinson's disease: Deep phenotyping, MDSGene literature review, and application of SynNeurGe criteria

Kleinz T, Cavallieri F, Borsche M, Toschi G, Valzania F, Fioravanti V, Valente EM, Mitrotti P, Avenali M, Zittel S, Born R, Matarazzo M, Di Fonzo A, Monfrini E, Radefeldt M, Santinelli L, Griebner N,

medRxiv [Preprint]. 2025 Jun 3:2025.06.03.25328628. doi: 10.1101/2025.06.03.25328628.

"Is sotagliflozin a 'wonder drug'? A review of its impact on cardiovascular, diabetic, renal, neuroprotective, and hepatic outcomes"

Fatima E, Irfan H, Fatima F, Jain J, Ur Rehman O, Sehar A, Ahmad B, Kumari S, Akilimali A.

Ann Med Surg (Lond). 2025 May 12;87(6):3700-3706. doi: 10.1097/MS9.0000000000003357. eCollection 2025 Jun.

Scrub typhus-associated movement and gait disorders: A systematic review with principal component analysis and in silico mechanistic modelling

Mondal R, Deb S, Dhauria M, Sen P, Sarkar V, Sarkar S, Chowdhury D, Lahiri D, Roy J, Benito-León J.

Trop Med Int Health. 2025 Jun;30(6):459-480. doi: 10.1111/tmi.14114. Epub 2025 Apr 21.

Representational Disparities in the Enrollment of Parkinson's Disease Clinical Trials

Tsai CC, Tao B, Lin V, Lo J, Brahmbhatt S, Kalo C, Marras C, Khosa F.

Mov Disord Clin Pract. 2025 Jun;12(6):878-881. doi: 10.1002/mdc3.70009. Epub 2025 Feb 17.

Efficacy and Safety of Magnetic Resonance-Guided Focused Ultrasound Thalamotomy in Essential Tremor: A Systematic Review and Metanalysis

Shiramba A, Lane S, Ray N, Gilbertson T, Srinivasaiah R, Panicker J, Radon M, Osman-Farah J, Macerollo A.

Mov Disord. 2025 Jun;40(6):1020-1033. doi: 10.1002/mds.30188. Epub 2025 Apr 17.

Impact of pharmacist-physician collaboration on patient outcomes in Parkinson's disease: a randomised controlled trial in tertiary care

Techa-Angkoon P, Pitakpatapee Y, Saengphatrachai W, Srivanitchapoom P, Suansanae T.

Int J Clin Pharm. 2025 Jun;47(3):834-843. doi: 10.1007/s11096-025-01883-6. Epub 2025 Feb 13.

Variants in ATP6V0C are associated with Dravet-like developmental and epileptic encephalopathy

Rong M, Marques PT, Ali QZ, Morcos R, Chandran I, Qaiser F, Møller RS, Bayat A, Rubboli G, Gardella E, Reuter MS, Sands TT, Scheffer IE, Schneider A, Poduri A, Wirrell E, Nabbout R, Sullivan J, Valent

Epilepsia. 2025 Jun;66(6):2046-2052. doi: 10.1111/epi.18346. Epub 2025 Mar 14.

Therapeutic Potential of PSC-derived Cell Transplantation in Parkinson's Disease: A Systematic Review and Meta-analysis of Preclinical Studies

Karimi A, Shiri Z, Tabrizi R, Naderi S, Salahi S, Elmi M, Baharvand H.

Curr Stem Cell Res Ther. 2025 Jun 11. doi: 10.2174/011574888X374086250602050549. Online ahead of print.

Diagnostic and Therapeutic Challenges in Lyme Disease and Co-Infections: Unraveling Neuropsychiatric and Neurological Complexities-A Comprehensive Case Series Analysis

Garg K, Booth R, Cobey A, Gilbert L, Ozdemir A.

Integr Med (Encinitas). 2025 Jun;24(3):10-27.

Inspiratory muscle training for people with Parkinson's disease: a protocol for a mixed methods randomised controlled trial

Fernandes Barreto de Mendonca J, Preston E, Flynn A, Bissett B.

BMJ Open Respir Res. 2025 Jun 22;12(1):e003120. doi: 10.1136/bmjresp-2024-003120.

Correction to: Assessing and managing bone health and fracture risk in Parkinson's disease: the BONE PARK 2 protocol

Age Ageing. 2025 May 31;54(6):afaf172. doi: 10.1093/ageing/afaf172.

Effect of vitamin D supplementation on motor symptoms in Parkinson's disease: a meta-analysis of randomized controlled trials

Xu J, Li J, Sun YJ, Quan W, Qin YD, Song J, Chen JJ.

Front Nutr. 2025 Jun 9;12:1500875. doi: 10.3389/fnut.2025.1500875. eCollection 2025.

An Updated and Comprehensive Review Exploring the Gut-Brain Axis in Neurodegenerative Disorders and Neurotraumas: Implications for Therapeutic Strategies

Hasan A, Scuderi SA, Capra AP, Giosa D, Bonomo A, Ardizzone A, Esposito E.

Brain Sci. 2025 Jun 18;15(6):654. doi: 10.3390/brainsci15060654.

Early parkinsonism masquerading as ocular myasthenia gravis

Rajasekar G, Mahalingam K, Kasturi N, Maruthasalam K.

BMJ Case Rep. 2025 Jun 15;18(6):e266371. doi: 10.1136/bcr-2025-266371.

More Than Three Decades After Discovery of the Neuroprotective Effect of PACAP, What Is Still Preventing Its Clinical Use?

Cherait A, Xifró X, Reglodi D, Vaudry D.

J Mol Neurosci. 2025 Jun 21;75(3):80. doi: 10.1007/s12031-025-02366-z.